254 related articles for article (PubMed ID: 11681716)
21. In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats.
Li SH; McNeill JH
Mol Cell Biochem; 2001 Jan; 217(1-2):121-9. PubMed ID: 11269655
[TBL] [Abstract][Full Text] [Related]
22. Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats.
Yuen VG; Pederson RA; Dai S; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1996 Sep; 74(9):1001-9. PubMed ID: 8960391
[TBL] [Abstract][Full Text] [Related]
23. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent.
Sánchez-González C; López-Chaves C; Trenzado CE; Aranda P; López-Jurado M; Gómez-Aracena J; Montes-Bayón M; Sanz-Medel A; Llopis J
ScientificWorldJournal; 2014; 2014():706074. PubMed ID: 24511298
[TBL] [Abstract][Full Text] [Related]
24. Insulin in combination with vanadate stimulates glucose transport in isolated cardiomyocytes from obese Zucker rats.
Huisamen B; Donthi RV; Lochner A
Cardiovasc Drugs Ther; 2001 Sep; 15(5):445-52. PubMed ID: 11855663
[TBL] [Abstract][Full Text] [Related]
25. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats.
Krook A; Kawano Y; Song XM; Efendić S; Roth RA; Wallberg-Henriksson H; Zierath JR
Diabetes; 1997 Dec; 46(12):2110-4. PubMed ID: 9392506
[TBL] [Abstract][Full Text] [Related]
26. Bis(maltolato)oxovanadium(IV) (BMOV) Attenuates Apoptosis in High Glucose-Treated Cardiac Cells and Diabetic Rat Hearts by Regulating the Unfolded Protein Responses (UPRs).
Cong XQ; Piao MH; Li Y; Xie L; Liu Y
Biol Trace Elem Res; 2016 Oct; 173(2):390-8. PubMed ID: 26983714
[TBL] [Abstract][Full Text] [Related]
27. [Hypoglycemic effects of bis(maltolato)oxovanadium administered by different routes upon diabetic rats].
Zhong XY; Zhang H; Zhang X; Lv WL; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):313-8. PubMed ID: 15205708
[TBL] [Abstract][Full Text] [Related]
28. Anti-diabetic activity of extract from Persea americana Mill. leaf via the activation of protein kinase B (PKB/Akt) in streptozotocin-induced diabetic rats.
Lima CR; Vasconcelos CF; Costa-Silva JH; Maranhão CA; Costa J; Batista TM; Carneiro EM; Soares LA; Ferreira F; Wanderley AG
J Ethnopharmacol; 2012 May; 141(1):517-25. PubMed ID: 22472105
[TBL] [Abstract][Full Text] [Related]
29. Bis(maltolato)-oxovanadium (IV)-induced phosphorylation of PKB, GSK-3 and FOXO1 contributes to its glucoregulatory responses (review).
Vardatsikos G; Mehdi MZ; Srivastava AK
Int J Mol Med; 2009 Sep; 24(3):303-9. PubMed ID: 19639221
[TBL] [Abstract][Full Text] [Related]
30. Hyperglycemia impairs the insulin signaling step between PI 3-kinase and Akt/PKB activations in ZDF rat liver.
Nawano M; Ueta K; Oku A; Arakawa K; Saito A; Funaki M; Anai M; Kikuchi M; Oka Y; Asano T
Biochem Biophys Res Commun; 1999 Dec; 266(1):252-6. PubMed ID: 10581198
[TBL] [Abstract][Full Text] [Related]
31. Neuregulin improves response to glucose tolerance test in control and diabetic rats.
López-Soldado I; Niisuke K; Veiga C; Adrover A; Manzano A; Martínez-Redondo V; Camps M; Bartrons R; Zorzano A; Gumà A
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E440-51. PubMed ID: 26714846
[TBL] [Abstract][Full Text] [Related]
32. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha.
Walker KS; Deak M; Paterson A; Hudson K; Cohen P; Alessi DR
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):299-308. PubMed ID: 9512493
[TBL] [Abstract][Full Text] [Related]
33. Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium.
Hei YJ; Chen X; Pelech SL; Diamond J; McNeill JH
Diabetes; 1995 Oct; 44(10):1147-55. PubMed ID: 7556949
[TBL] [Abstract][Full Text] [Related]
34. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states.
Standaert ML; Sajan MP; Miura A; Kanoh Y; Chen HC; Farese RV; Farese RV
J Biol Chem; 2004 Jun; 279(24):24929-34. PubMed ID: 15069067
[TBL] [Abstract][Full Text] [Related]
35. Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity.
Semiz S; McNeill JH
Mol Cell Biochem; 2002 Jul; 236(1-2):123-31. PubMed ID: 12190110
[TBL] [Abstract][Full Text] [Related]
36. Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes.
Dabroś W; Kordowiak AM; Dziga D; Gryboś R
Pol J Pathol; 1998; 49(2):67-76. PubMed ID: 9798409
[TBL] [Abstract][Full Text] [Related]
37. Effect of bis(maltolato)oxovanadium (IV) (BMOV) on selenium nutritional status in diabetic streptozotocin rats.
Sanchez-Gonzalez C; Bermudez-Peña C; Guerrero-Romero F; Trenzado CE; Montes-Bayon M; Sanz-Medel A; Llopis J
Br J Nutr; 2012 Sep; 108(5):893-9. PubMed ID: 22085676
[TBL] [Abstract][Full Text] [Related]
38. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.
Kordowiak AM; Dziga D; Dabroś W
Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667
[TBL] [Abstract][Full Text] [Related]
39. Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats.
Bhanot S; Bryer-Ash M; Cheung A; McNeill JH
Diabetes; 1994 Jul; 43(7):857-61. PubMed ID: 8013747
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle.
Oku A; Nawano M; Ueta K; Fujita T; Umebayashi I; Arakawa K; Kano-Ishihara T; Saito A; Anai M; Funaki M; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2001 May; 280(5):E816-24. PubMed ID: 11287365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
